Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Modulators of metabotropic glutamate receptors disclosed by Roche

Nov. 27, 2000

Novel pharmaceutical compositions prepared for rosiglitazone

Nov. 27, 2000

Selective delta opioid receptor agonists in the SB pipeline

Nov. 24, 2000

Merck's new integrin receptor antagonists for thrombosis, osteoporosis, atherosclerosis

Nov. 24, 2000

New erythromycin-based antimicrobial agents identified at Pliva

Nov. 24, 2000

Novo Nordisk presents new series of PPAR-activating compounds for diabetes and obesity

Nov. 24, 2000

U.S. university researchers synthesize new heregulin antagonists based on rifamycin structure

Nov. 24, 2000

Anticancer platinum complexes designed at Unitech

Nov. 24, 2000

Bradykinin antagonists and their use in the treatment of pain claimed in recent patent

Nov. 24, 2000

NPY receptor ligands synthesized at Meiji Seika reduce food intake in animals

Nov. 23, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...